Activation of Dendritic Cells via Inhibition of Jak2/STAT3 Signaling1
暂无分享,去创建一个
Daniele M. Gilkes | S. Sebti | A. Beg | D. Gabrilovich | M. Blaskovich | P. Cheng | Y. Nefedova | Yulia Nefedova
[1] C. Jobin,et al. STAT3 regulates NF-κB recruitment to the IL-12p40 promoter in dendritic cells , 2005 .
[2] D. Gabrilovich. Mechanisms and functional significance of tumour-induced dendritic-cell defects , 2004, Nature Reviews Immunology.
[3] W. Reith,et al. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells , 2004, Nature Immunology.
[4] R. Jove,et al. Hyperactivation of STAT3 Is Involved in Abnormal Differentiation of Dendritic Cells in Cancer , 2004, The Journal of Immunology.
[5] D. Altieri,et al. Full-length dominant-negative survivin for cancer immunotherapy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] R. Flavell,et al. STAT3 is required for Flt3L-dependent dendritic cell differentiation. , 2003, Immunity.
[7] Hua Yu,et al. A critical role for Stat3 signaling in immune tolerance. , 2003, Immunity.
[8] Bin Yu,et al. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. , 2003, Cancer research.
[9] R. Steinman. Some interfaces of dendritic cell biology , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[10] J. Turkson,et al. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. , 2003, Cancer research.
[11] E. Fikrig,et al. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: A critical role of STAT3 in innate immunity , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[12] Wenzheng Zhang,et al. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. , 2002, The Biochemical journal.
[13] Ye Zheng,et al. Dendritic Cell Development and Survival Require Distinct NF-κB Subunits , 2002 .
[14] B. Osborne,et al. Notch-1 Regulates NF-κB Activity in Hemopoietic Progenitor Cells1 , 2001, The Journal of Immunology.
[15] Antonio Lanzavecchia,et al. Regulation of T Cell Immunity by Dendritic Cells , 2001, Cell.
[16] S. Rane,et al. Janus kinases: components of multiple signaling pathways , 2000, Oncogene.
[17] R. Steinman,et al. Transport of peptide-MHC class II complexes in developing dendritic cells. , 2000, Science.
[18] R. Steinman,et al. Developmental regulation of MHC class II transport in mouse dendritic cells , 1997, Nature.
[19] D. Carbone,et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.
[20] David Baltimore,et al. Regulation of the NF-?B/rel transcription factor and I?B inhibitor system , 1993 .
[21] Hua Yu,et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells , 2004, Nature Medicine.
[22] Ye Zheng,et al. Dendritic cell development and survival require distinct NF-kappaB subunits. , 2002, Immunity.
[23] W. Reith,et al. The bare lymphocyte syndrome and the regulation of MHC expression. , 2001, Annual review of immunology.
[24] W. Leonard,et al. The Jak-STAT pathway. , 2000, Molecular immunology.
[25] C Caux,et al. Immunobiology of dendritic cells. , 2000, Annual review of immunology.